Skip to main content
. 2019 Jul 18;2019:5376439. doi: 10.1155/2019/5376439

Figure 9.

Figure 9

FSM upregulates the activity of serum antioxidant enzyme GSH-Px, SOD, and CAT after 42-d treatment (72 d of total duration of diabetes). (a) The serum activity of GSH-Px; (b) the serum activity of SOD; (c) the serum activity of CAT. Values are presented as mean ± SD, n=8. ∗p < 0.05, ∗∗p < 0.01: untreated diabetic model group, CaD group, FSM high-dose, FSM medium-dose, and FSM low-dose group vs normal group; #p < 0.05, ##p < 0.01: CaD group, FSM high-dose, FSM medium-dose, and FSM low-dose group vs untreated diabetic model group.